Purified Epidermal Pentapeptide Inhibits Proliferation and Enhances Terminal Differentiation in Cultured Mouse Epidermal Cells  by Elgjo, Kjell et al.
REPORTS 
Purified Epidermal Pentapeptide Inhibits 
Proliferation and Enhances Terminal Differentiation 
in Cultured Mouse Epidermal Cells 
Kjell Elgjo, M .D., * Karl L. Reichelt, M.D., Henry Hennings, Ph.D., Delores Michael, and 
Stuart H. Yuspa, M.D. 
Institute of Pathology (KE) and Pediatric Research Institute (KLR), Rikshospitalet, Oslo, Norway, and Laboratory of Cellular 
Carcinogenesis and Tumor Promotion, National Cancer Institute (HH, OM, SHY) , Bethesda, Maryland, U.S . A. 
Skin extracts contain an epidermal mitosis inhibitor that 
recently has been purified and identified as a penta peptide. 
To develop an in vitro assay system for further biologic 
characterization, primary mouse epidermal cells and an es-
tablished mouse epidermal cell line (line 308) were used for 
testing of the purified pentapeptide. In primary cell cultures 
the mitotic activity, as estimated by means of vinblastine, 
was reversibly inhibited by 44% at a peptide concentration 
of 10 - 8 M in high-calcium (1.2 mM Ca + +), and by 27-
38% at peptide concentrations of10 - 1o and 10- 8 M in low-
calcium (0.02 mM Ca + +) m edium . The 308 cell s were 
Several features of in vitro cell growth are difficult to explain based only on what is known about stimulatory factors found in serum or added to the medium . It is probable that grow th-regul ating inhibitors are also im-portant in many in vitro cell systems [1-5] . This aspect 
of in vitro growth was exploited in the present study of a recently 
described endogenous penta peptide that inhibits epidermal mi-
totic activity in vivo [6]. 
The first purified inhibitor contained the amino acids gluta-
• mate, aspartate, serine, glycine, and alanine [6]. After modifi-
cation of the purification procedures, and using the fractionation 
methods outlined below, an alanine-con tainin g peptide could be 
separated from the inhibitory fraction, which consisted of the 
amino acids pyroglutamate, glutamate, aspartate, serine, and gly-
cine, with pglu at the N terminal end [7]. 
The epidermal penta peptide was purified from water extracts 
of mouse skin as part of a study of epidermal growth regu lation. 
It has been known for about 20 years that such skin extracts will 
inhibit epidermal cell prolifera tion in a reversible and seemingly 
tissue-specific way both in vivo and in vitro [8,9]. The inhibitory 
principle has been named "chalone" [10] but no single inhibitory 
substance has previously been identified in skin extracts. 
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inhibited by 46% at a peptide concentration oflO - 6 M but 
only after the cells had reached near-confluence and had a 
moderate rate of proliferation . A low concentration of 
adrenalin (0.18 p,g/ ml) in the medium rendered the pri-
mary cultures more sensitive to the peptide. After repeated 
peptide trea tments over 24 h , the number of cornified 
envelopes (a marker of terminal diffe rentiation) was in-
creased both in primary cu ltures and in the 308 cell s. The epi-
d ermal penta peptide thus seems to influence both prolif-
eration and terminal differentiation in cultured mouse 
epidermal cells. } Illv est Denllatol 87:555-558, 1986 
To examine further the mode of action of the epidermal pen-
tapeptide we wanted to look at its effects on epide~ma l cells in 
the absence of other tissues and cell types. For this purpose we 
chose a well-established in vitro system usin g either primary epi-
derm al cell cultures o r established cell lines derived from mouse 
epidermis. 
MATERIALS AND METHODS 
Cell Cultures Epidermal cells from newborn BALB/c mice 
were prepared as previously described [11] and cultured under 
low- or high-calcium conditions as described by Hennings et al 
[12]. Four million cells were plated in 60-mm plastic dishes and 
grown in Eagle's medium (Eagle's no . 2, NIH M edia Unit) with 
8-10% fetal bovine serum (FBS) (Reheis), nonessential amino 
acids, and 1 % Antiobiotic-Antimycotic (GIBCO). Calcium-free 
medium and chelated FBS were used to prepare low-calcium 
medium (0.02 mM Ca + +). An established nontumorigenic cell 
line (308 cells) derived from carcinogen-treated adult mouse skin 
[13] was used in some experiments. These cells were grown in 
the same type of medium but with 1.2 mM calcium and under 
the same conditions as the primary celJ s. 
Assays for Proliferation or Differentiation The rate of cell 
division was estimated by means of vinblastine (VLB) (Eli Lilly 
and Company). Vinblastine was added to a final concentration 
of 25 ng/ml to arrest dividing cells in metaphase. Preliminary 
experiments had shown that VLB at this concentration will arrest 
all mitoses for a period of 4 h in primary cultures of epidermal 
cells, and for a period of 3 h in rapidly proliferating 308 cells. In 
all experiments the cells were fixed in 1: 3 glacial acetic acid: ethanol 
after 3 h of exposure to VLB. Before fixation the mitoses were 
spread by exposing them for 10 min to .l: 4 phosphate-buffered 
saline: distilled water solution . After staining with hematoxylin, 
mitoses were counted among 2000-5000 cells, and the mitotic 
rate expressed as the number of cells entering mitosis per 1000 
cells /3 h. 
Terminal differentiation was quantified by estimating the pro-
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portion of cell s with cornified envelopes. Attached and unattached 
cell s were extra cted with 2% sodium dodecyl sulfate (SDS)-20 
mM dithiothreito l as described by Rice and Green [14] and by 
Hennings et al [15]. The proportion o f cornifi ed cells is given as 
percent o f the tota l number of cells. 
The Wilcoxon rank sum test w as used to calculate th e statisti ca l 
signifi cance of observed differences. 
Preparation of Inhibitor Freeze-dried water extracts of hair-
less mouse skin were trea ted w ith 1 M acetic acid to dissociate 
pep tides from protein ca rriers, fo llowed by fractionation on a 
Sephadex G-25 gel to separate macromolecules from low-mo-
lecul ar-weight pep tides and other compounds. The active, inhib-
itory frac tion was th en subj ected to the foll owin g fractionation 
procedures: C-18 reversed phase (Bondapak C-1 8/Porasil B 37-
75 mi crons); ca ti on exchange on Dowex 50; anion exchange on 
Dowex 1; Fractogel MG 2000; hi gh-perfo rm ance liquid chro-
matography (HPLC) separation on Partisil M-9; and HPLC re-
chromatogra phy of the active fra ction. Amino acid anal ysis after 
acid hydrolys is of the active HPLC rechromatography fraction 
yielded an amino acid composition of glx2, asx ' , serO.9 , and glyl. 
Wh en the pyrog lu-ring was opened with 4 M HCI in anhydrous 
methanol, the fragments glu-g lu and (asp, ser, gly) were obtained. 
A t all steps the fra ctions were tested blind in hairless mice. 
RESULTS 
Cultures of prim,ary epidermal cells were grown in hi gh- or low-
calcium medium for 3-4 days. Peptide at different concentrations 
and VLB were th en added and the cells grown for 3 h befo re 
fi xat ion. 
Figure 1 shows that a peptide concentration oflO- 8 M inhibited 
the mitoti c rate by almost 50% in cells growin g in high-calcium 
medium. Higher or lower peptide concen trations gave no statis-
ti ca ll y significant inhibition (p > 0.05). Also cell s growin g in 
low-ca lcium med ium were inhibited by 40% at a peptide con-
centration of 10- 8 M but these cells were signifi cantly inhibited 
also at a lower peptide concentration of 10- 10 M. Inhibi tion found 
at even lower concentrations were not statisticall y signifi cant 
(p > 0.05) as ca lculated with th e nonparametri c Wilco xon test. 
Bu llough and Laurence [8] have shown that adrena li n enhances 
the inhibitory effect of skin extra cts on the mitotic rate in mouse 
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Figurc 1. Primary epidermal ce lls we re g rown for 3-4 days in medium 
w ith 0 .2 mM (opell bars) or 1.2 111M (shaded bars) calcium . Peptide was 
added at the indicated concentrations togethe r w ith V LJ3 and the cel ls 
g rown fo r 3 h before fi xa tion . The resu lts ± I SE (bars) are given as 
pe rcentages of the contro l va lues , w hich in high-calcium medium were 
15.5 ± 1. 4 and in low-calcium cultures 11 .7 ± 0.8 arres ted mitoses per 
1000 cel ls per 3 h . The number of dishes is g iven ill parcllrh eses . 
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Figurc 2. Primary epiderma l cells were g rown in low-calcium medium 
for 3-4 days. Peptide at the indicated concentrations was added together 
with VLD and adrenalin (0.18 ILg/ ml) , and the ce lls grown for 3 h befo re 
fi xa tion. The results ± 1 SE (bars) are g iven in percentages of the contro l 
va lue, w hich in thi s experimen t was 15. 1 ± 0.6 mitoses per 1000 cells 
per 3 h. The number o f di shes is g iven ill paretlrheses. 
ear epidermis in vitro. To tes t whether adrenalin could modify 
the inhibition induced by purifi ed peptide, primary epidermal 
cells grown in low-calcium medium for 3 days were treated with 
peptide at different concentrations together with adrenalin (0.18 
/Lg/ ml). Preliminary experiments showed that adrenalin alone had 
no effect at this concentration. Figure 2 shows that the mitotic 
rate was inhibited by 25% and 38% at peptide concentrations 
10 - 10 M or 10 - 12 M, respectively. At a peptide concentration of 
10- 8 M, which gave maximal inhibition in the absence of adren-
alin , no effect was seen. 
The lack of response at peptide concentrations lower than 10 - 10 
M in the first ex periment could be related to the duration of the 
assay period. An initial and reversible short delay of cells in the 
G2 phase would be missed if the inhibited cells were released and 
entered mitosis within 3 h after the start of the block. To examine 
this possibility primary cultures were grown in high-calcium me-
dium for 3-4 days . Low doses of peptide were given at the start 
of the assay period, and after 1 and 2 h. 
Table I shows th at th e mitoti c rate was inhibited by 33% and 
45% at peptide concentrat ions of 10- 10 M and 10- 12 M, respec-
tively , when the peptide was added at 1-h intervals. It therefore 
seems likely that addition of low doses of peptide (below 10- 8 
M) was follow ed by a short-lastin g and fu lly reversible period of 
inhibition , and that this transient delay in the premitotic phase(s) 
was prolonged when the cells were exposed to repeated doses of 
peptide. The reversibility of the initial mitotic inhibition was 
corroborated by an experiment (not shown) that demonstrated 
that the rate of cell division was normal at 12 and 24 h after 
Table I. Effect on Prin'l3ry Cultures of Repea ted Treatments 
with Peptide 
Peptide 
Concentration (M) 
10- 10 
10- 12 
Controls 
Mitotic Rate per 
1000 Cells/3 h 
10.7 ± 2.9 (3) 
8.5 ± 1. 9(6) 
15.5 ± 1.2 (6) 
Effect 
-33% * 
- 45% * 
Cell s were grown in high-ca lcium (1.2 mM Ca + +) medium for 3 da ys. Peptide 
at the indica ted doses was added at t = 0, t = I, and t = 2 h. Vinblastine was 
added togeth'er with the first dose of peptide. The cells were fixed at t = 3 h. 
Number of dishes is given ill pare/ltlleses. * = p < 0.05. 
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Figure 3. Cells of the 308 line were grown ill mediulll with 1.2 mM 
calcium for 14 days (OpC II bars) or 5 days (shaded bill'S). Peptide at the 
ind ica ted concentrations was added together with VLB and the cells fixed 
3 h late r. The results arc given as percentages of the control va lues 
:±: SE. which in theI4-day-old cells were 57. 1 :±: 4.3 and in the 5-day-
old cells 159.9 :±: 5.3 arres ted mitoses per 1000 cells per 3 h. The nUlllber 
of dishes is given ill pllrclllhescs. 
treatment with a single dose of peptide that gave optimal effect 
in the experiment shown in Table I. 
Ln the next experiment we tested the established 308 cells fo r 
their response to the epiderm al peptide. We also wanted to ex-
amine whether the response was related to the rate of cell pro-
liferation. During the first 3-10 days after plating 308 cel ls pro-
liferate rapidly. but after 2 weeks in culture the rate is reduced as 
conflu ence is reached. The 308 cells were therefore grown for 3 
to 14 days in high-calcium medium before they were treated w ith 
peptide. 
Figure 3 shows that the mitotic rate in slow-growing 308 cells 
was inhibited by 46% at a peptide concentration of 10- 6 M w hile 
rapidly growing 308 cells remained unaffected at all peptide con-
centrations tested. A co m parison with Fig 1 demonstrates that 
the peptide concentration needed to reduce the mi tot ic rate in 
slow-growing 308 cells was 100 times higher than that needed to 
inhibit the primary cell cultures to a similar exten t. 
To test whether the penta peptide could modify differentiation, 
cultures of primary cells were grown in low-calcium med ium for 
3 days and 308 cells in hi gh-calcium medium for 14 days. The 
percentage of corni fi ed envelopes was es tim ated after treating the 
cells 3 times over a 24-h period. . 
Table II shows that in both primary wltures and in 308 cells 
Table II. Effect of Peptide on Termina l D ifferentiation 
Peptide 
Cell Type Concentration (M) 
Pri mary 
Primary 
308 cells 
308 cel ls 
308 cells 
308 cel ls 
10 - 8 
o 
10- 6 
10- 8 
10- 9 
o 
Cornified Envelopes (%) 
Unattached Cells Attached Cells 
0.73 ± 0. 18 
0.43 ± 0.09 
3.05 ± 0.03 
1.91 ± 0.06 
1.23 ± 0.20 
0.75 ± 0. 14 
0.23 ± 0.03 
0.26 ± 0.15 
0.025 ± 0.008 
0.100 ± 0.006 
0.053 ± 0.008 
0.100 ± 0.012 
Primary epidermal cell cu ltu res grow n for 3 days in low-calcium (0.02 mM Ca + +) 
and 308 cells for 14 days in high-calcium (1.2 mM Ca++) med iulll were treated 3 
times at 6-h interva ls with peptide at the indicated concentration. Two dishes fro m 
each gro up were pooled and assa yed for co rnified envelopes at 24 h after the first 
treatmcnC". T he results for (he primary cells represent the averages of2 ex periments. 
Only I experiment was made with the 308 cells. All figures arc given with their 
SEM . 
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the treatm ent increased the number of cornifi ed un attached cells 
w ith no discernable effect on the attached cells. Only one dose 
was used in primary cul tures, but in 308 cells the effect was dose-
related. 
D ISCU SS IO N 
N ormal cells are often difficult to grow in vitro, even with the 
most advanced techniques. As a natural conseq uence of this, mu ch 
work has been devoted to findin g suitable media and stimulatory 
facto rs that fac ilitate in v itro cell proliferation . Little attention has 
been given to possible endogenous inhibitors in such systems. 
Despite the dominating interest in stimulating growth factors 
in vi tro a number of independent experiments have indicated that 
contact and density inhibition could be due to inhibitor(s) produced 
by the cells in culture and secreted in to the medium [1-5,16,17]. 
This concept is in good agreemen t with other in vivo findings 
suggesting that normal in vivo growth regulation is based on a 
negative feedback principle [7,9,18,19]. 
P urifi cation and charac terization of growth-regu lating inhibi-
to rs have been difficult, but in 1982 Paukovits and Laerum [20] 
described a penta peptide in granu locytes that inhibits granulo-
poiesis in vitro and in vivo. In 1984, we reported on a biochem-
ically similar penta peptide in extracts of mouse skin [6] . The 
purified epiderm al penta peptide (EPP) inhibi ts the epidermal mi-
totic rate at very low doses when given i. p. to mice. 
The present study showed that EPP inhibited the mitoti c rate 
both in primary cultures of mouse epidermal cells and in an es-
tablished cell line derived from ca rcinogen- treated ad ult mouse 
epidermis. In all experi ments only a certain limited dose ran ge 
had a sign ificant inhi bitory effect. T he optimal dose range was 
low in all experiments, even for the "slow-growing" 308 cells 
that needed a concen tration oflO - 6 M to respond (about 4.5 JL gl 
ml). T he dose range that was inhibitory to primary cell cultures 
corresponds to the in vivo dose [6,7] . The low active dose and 
the restricted dose range could indica te that the pentapeptide binds 
to a specific receptor on the cells. Moreover, th e bell-shaped dose-
response curve is simila r to that fo und for some other biologica lly 
active peptides and for several hormones and enzy mes [21-24] . 
Growth and differentiation of cultures of primary mouse epi-
dermal cells depend on the calcium concentration in the medium 
[11] . T he cells grow as a monolayer in medium containing 0.02-0.10 
mM calcium. [n medium with standard calcium levels (1.2-1.8 
mM) ~he cells gradually stop growing and terminally differentiate 
over a period of about 2 weeks. T he present stud y showed that 
primary epidermal cells in low-calcium medium were inhibited 
by a dose that was 100 times lower than that needed for cells in 
high-calcium medium, indicating that the effects of the penta-
peptide are related to the extracellular concentration of calcium, 
or to the sta te of differentiatio n. Since EPP was acti ve at very 
low doses even in high-calcium medium this relationship must 
be limited. 
[n 1964 Bullough and Laurence [8,25] reported that the inhib-
itory effect of crude and partiall y purified skin extracts on epi-
dermal cell proliferation in vitro was enhan ced by ad rena lin . In 
o ur experim ent, too, addition of a low dose of ad renalin increased 
the susceptibility of the cells to EPP. The interaction between 
adrenalin and EPP seems to be complex, since adrenalin decreased 
the optimal EPP concentration range in such a way that the dose 
that was most inhibitory without adrenalin was without effect in 
the presence of this agent . 
A short-lasting and reversible mitotic inhibition w ill be missed 
in our assay system if the ar rested cells resum e their cell cycle 
traverse and enter mitosis within the duration of the experi ment. 
T he fi ndin gs shown in Table I demonstrated that such a short 
arrest of G2 cells probably occurred at low dose levels. T he ex-
periment also showed that it is difficult to define an opti mal dose 
range for EPP without reference to the test system. 
EPP inhibited 308 cel ls onl y when the mitotic rate was relatively 
low. T he lack of effect in rapidly growing cells and the higher 
dose needed to inhibit them could be related to the duration of 
558 ELGJO ET AL 
th e mitotic arrest, as discussed above. Because of a limited supply 
ofEP P no experimen ts were condu cted w ith repeated treatments. 
O n the o ther hand , the difference between th e 308 cells and the 
prim ary cultures in their res ponse to EPP could be due to the fac t 
that the 308 cel ls represent an established cell line. In some in 
vitro experiments malignant cells have been unrespOli sive to en-
dogenous inh ibito rs [26,27], while oth ers have found cell-specifi c 
inhibi tors even in malignant cell systems [27-32). In some of the 
cell lines the response was dependent on the rate of cell prolif-
eration [33], and some malignant cells were less sensitive than 
th eir norm al counterparts [34] . 
O ur assay system w ith VLB to arrest mitoses will register 
effects onl y on ceUs in the G2 phase. However, the increased 
number of cornifi ed envelopes fo llowing EPP treatment indicates 
that the peptide induced a certain number of cells to terminall y 
diffe renti ate. T he effect o f E PP is therefore not res tri cted to a 
reversible arrest o f G2 cells but seems to involve a more funda-
mental change in cell programming. 
A large number of growth fac to rs is known, but we still lack 
information about the basic, regulatory mechanisms th at maintain 
constant o rga n size in an adult orga rusm . Such a control mech-
anism must be based on a nega tive feedback prin ciple, acting by 
means o f qui ck and short-l as tin g signal substances. The name 
"chalone" has been suggested fo r this type o f g row th regul ators 
[1 0]. T he EPP could represent a component of such 3n inhibitory 
signaJ in epidermis. The fact that the penta peptide has similar 
inhibito ry effects on proliferating epidermal cells in vitro as in 
vivo should facilitate furth er work to characterize how it acts on 
target cells and in teracts w ith other grow th fac tors. 
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